Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,444 across all filing types
Latest filing 2013-12-22 Major Shareholding Noti…
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Becoming a substantial holder 2 pages 1.3MB
Major Shareholding Notification Classification · 95% confidence The document contains detailed tables listing securities holdings, voting power, dates of acquisition, and consideration amounts related to a specific shareholder or nominee entity. It also includes a signature section for a director. The content focuses on shareholding details and transactions by a significant shareholder or nominee, rather than financial results, management changes, or meeting materials. There is no indication of a full report or announcement of voting results, nor is it a regulatory certification or a general regulatory filing. The detailed shareholding information and acquisition dates suggest this is a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2013-12-22 English
Results of Meeting 1 page 137.0KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF GENERAL MEETING' and provides detailed voting results for resolutions considered at a General Meeting of shareholders. It references compliance with ASX Listing Rule 3.13.2 and the Corporations Act 2001, which govern disclosure of voting outcomes. The content includes vote counts for each resolution, indicating it is an official announcement of voting results rather than the meeting materials or the meeting itself. The document length is short (1883 characters), and it does not contain financial statements or management discussion. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2013-12-19 English
Appendix 3B and Section 708A Notice 13 pages 439.1KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to these securities. The content includes detailed information about the class and number of securities issued, terms of the securities, escrow conditions, issue price, purpose of the issue, shareholder approvals, and quotation agreements. It also includes calculations related to placement capacity under ASX rules. This document is clearly an announcement regarding capital raising and securities issuance activities, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief notice or a report publication announcement but a substantive update on capital activities.
2013-12-19 English
Settlement of Biolife Science Qld Ltd Acquisition 1
M&A Activity Classification · 95% confidence The document announces the settlement of an acquisition (Biolife Science Qld Ltd) by Imugene, including shareholder approvals, issuance of shares as consideration, and changes in the board of directors. It details the completion of the acquisition transaction and related corporate governance changes. There is no detailed financial report or comprehensive financial data presented, nor is it a full annual or interim report. The document is an announcement related to a merger/acquisition event and changes in management. Therefore, it fits best under the category of M&A Activity (TAR) because it announces the completion of an acquisition and related shareholder approvals and share issuance.
2013-12-19 English
Becoming a substantial holder 2 pages 108.1KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001. It details the substantial shareholding of WebInvest Pty Ltd in Imugene Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding change, specifically the initial substantial holder notice. It is not an annual report, earnings release, or any other financial report but a regulatory disclosure about share ownership levels crossing thresholds. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2013-12-19 English
Imugene Secures Important Intellectual Property 1 p
Regulatory Filings Classification · 90% confidence The document text is very short (2649 characters) and mostly consists of unintelligible or corrupted text with some headings and a brief title mentioning 'Imugene Secures Important Intellectual Property Associated with Biolife Science Acquisition'. There is no substantive financial data, no detailed report content, and no clear indication of a full report. The text appears to be an announcement or news release rather than a full report. Given the short length and the nature of the content, it is likely an announcement related to a corporate event or update. Since it does not fit neatly into other categories and is not a full report, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements and filings that do not fit elsewhere.
2013-12-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.